The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis.
<h4>Background</h4>Studies of anti-angiogenic agents (AAs), combined with chemotherapy (chemo) or as monotherapy in metastatic oesophago-gastric cancer (mOGC), have reported mixed outcomes. We undertook systematic review and meta-analysis to determine their overall benefits and harms.<...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0172307 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850169594843496448 |
|---|---|
| author | David L Chan Katrin M Sjoquist David Goldstein Timothy J Price Andrew J Martin Yung-Jue Bang Yoon-Koo Kang Nick Pavlakis |
| author_facet | David L Chan Katrin M Sjoquist David Goldstein Timothy J Price Andrew J Martin Yung-Jue Bang Yoon-Koo Kang Nick Pavlakis |
| author_sort | David L Chan |
| collection | DOAJ |
| description | <h4>Background</h4>Studies of anti-angiogenic agents (AAs), combined with chemotherapy (chemo) or as monotherapy in metastatic oesophago-gastric cancer (mOGC), have reported mixed outcomes. We undertook systematic review and meta-analysis to determine their overall benefits and harms.<h4>Methods</h4>Randomized controlled trials in mOGC were sought investigating the addition of AAs to standard therapy (best supportive care or chemo). The primary endpoint was overall survival (OS) with secondary endpoints progression-free survival (PFS), overall response rate (ORR) and toxicity. Estimates of treatment effect from individual trials were combined using standard techniques. Subgroup analyses were performed by line of therapy, region, age, performance status, histological type, number of metastatic sites, primary site, mechanism of action and HER2 status.<h4>Results</h4>Fifteen trials evaluating 3502 patients were included in quantitative analysis. The addition of AAs was associated with improved OS: HR 0·81 (95% CI 0·75-0·88, p<0·00001) and improved PFS: HR 0·68 (95% CI 0·63-0·74, p<0·00001). Subgroup analyses favoured greater benefit for OS in 2nd/3rd line settings (HR 0·74) compared to 1st-line settings (HR 0·91) (X2 = 6·00, p = 0·01). OS benefit was seen across all regions-Asia (HR 0·83) and rest of world (HR 0·75)-without significant subgroup interaction. Results from 8 trials evaluating 2602 patients were pooled for toxicity > = Grade 3: with OR 1·39 (95% CI 1·17-1·65).<h4>Conclusions</h4>The addition of AAs to standard therapy in mOGC improves OS. Improved efficacy was only observed in 2nd- or 3rd-line setting and not in 1st-line setting. Consistent OS benefit was present across all geographical regions. This benefit is at the expense of increased overall toxicity. |
| format | Article |
| id | doaj-art-33d9c021ca5641268cd8fd7cd72c84ff |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-33d9c021ca5641268cd8fd7cd72c84ff2025-08-20T02:20:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017230710.1371/journal.pone.0172307The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis.David L ChanKatrin M SjoquistDavid GoldsteinTimothy J PriceAndrew J MartinYung-Jue BangYoon-Koo KangNick Pavlakis<h4>Background</h4>Studies of anti-angiogenic agents (AAs), combined with chemotherapy (chemo) or as monotherapy in metastatic oesophago-gastric cancer (mOGC), have reported mixed outcomes. We undertook systematic review and meta-analysis to determine their overall benefits and harms.<h4>Methods</h4>Randomized controlled trials in mOGC were sought investigating the addition of AAs to standard therapy (best supportive care or chemo). The primary endpoint was overall survival (OS) with secondary endpoints progression-free survival (PFS), overall response rate (ORR) and toxicity. Estimates of treatment effect from individual trials were combined using standard techniques. Subgroup analyses were performed by line of therapy, region, age, performance status, histological type, number of metastatic sites, primary site, mechanism of action and HER2 status.<h4>Results</h4>Fifteen trials evaluating 3502 patients were included in quantitative analysis. The addition of AAs was associated with improved OS: HR 0·81 (95% CI 0·75-0·88, p<0·00001) and improved PFS: HR 0·68 (95% CI 0·63-0·74, p<0·00001). Subgroup analyses favoured greater benefit for OS in 2nd/3rd line settings (HR 0·74) compared to 1st-line settings (HR 0·91) (X2 = 6·00, p = 0·01). OS benefit was seen across all regions-Asia (HR 0·83) and rest of world (HR 0·75)-without significant subgroup interaction. Results from 8 trials evaluating 2602 patients were pooled for toxicity > = Grade 3: with OR 1·39 (95% CI 1·17-1·65).<h4>Conclusions</h4>The addition of AAs to standard therapy in mOGC improves OS. Improved efficacy was only observed in 2nd- or 3rd-line setting and not in 1st-line setting. Consistent OS benefit was present across all geographical regions. This benefit is at the expense of increased overall toxicity.https://doi.org/10.1371/journal.pone.0172307 |
| spellingShingle | David L Chan Katrin M Sjoquist David Goldstein Timothy J Price Andrew J Martin Yung-Jue Bang Yoon-Koo Kang Nick Pavlakis The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis. PLoS ONE |
| title | The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis. |
| title_full | The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis. |
| title_fullStr | The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis. |
| title_full_unstemmed | The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis. |
| title_short | The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis. |
| title_sort | effect of anti angiogenic agents on overall survival in metastatic oesophago gastric cancer a systematic review and meta analysis |
| url | https://doi.org/10.1371/journal.pone.0172307 |
| work_keys_str_mv | AT davidlchan theeffectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT katrinmsjoquist theeffectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT davidgoldstein theeffectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT timothyjprice theeffectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT andrewjmartin theeffectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT yungjuebang theeffectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT yoonkookang theeffectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT nickpavlakis theeffectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT davidlchan effectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT katrinmsjoquist effectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT davidgoldstein effectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT timothyjprice effectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT andrewjmartin effectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT yungjuebang effectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT yoonkookang effectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis AT nickpavlakis effectofantiangiogenicagentsonoverallsurvivalinmetastaticoesophagogastriccancerasystematicreviewandmetaanalysis |